Browse all practice questions for the Certified Specialist in Obesity and Weight Management (CSOWM) Practice Exam. Search by topic, open any question and review its full explanation, then test yourself in the practice quiz.

Certified Specialist in Obesity and Weight Management (CSOWM) Practice Exam course image
More practice questions

These questions are part of the practice quiz. Start practicing

  • Which statement about bariatric surgery in the United States is true?
  • According to ADA guidelines, which diabetes medication class is associated with the most weight loss?
  • Bariatric surgery is considered for patients with which weight criteria?
  • Which biological mechanism explains increased hunger on a low-calorie diet due to reduced signaling in the hypothalamus?
  • Name the three common bariatric procedures and state how each achieves weight loss.
  • During a prolonged Roux-en-Y gastric bypass surgery, a patient develops dark urine with low urine output, edema, hyperkalemia, elevated creatinine, and very high CK. What is the most likely explanation for this patient’s acute renal failure?
  • Which statement best describes obesity management?
  • Which statement about obesity as a disease is most accurate?
  • For a 45-year-old woman with BMI 31.5 starting a weight-loss plan, which dietary target best aligns with guidelines?
  • Which patient has an indication for antiobesity medication?
  • Name three metabolic risk factors that typically improve with weight loss.
  • Based on the Weight Watchers example, how many additional daily calories are from uncounted fruit if 6 servings per day are consumed?
  • Adaptive thermogenesis is another name for which phenomenon observed after weight loss?
  • How should adverse effects encountered with weight loss pharmacotherapy be managed?
  • In SURMOUNT-1, what was the weight loss at the highest tirzepatide dose compared with placebo?
  • What tool is used to categorize obesity severity and guide therapy in practice guidelines?
  • How do electronically delivered weight loss programs compare to face-to-face interventions, according to guidelines?
  • Which biochemical tests should be ordered for a patient one year after Roux-en-Y gastric bypass?
  • How do weight loss medications typically affect blood pressure?
  • Which class of medications includes liraglutide and semaglutide used for weight management?
  • Which measurement is used alongside BMI to assess central adiposity and cardiometabolic risk?
  • In a 45-year-old patient with obesity, elevated TSH and normal free T4, what is the best initial treatment?
  • Which type of exercise is most effective for increasing basal metabolic rate?
  • Which statement about glycemic index is true?
  • Which weight loss range is expected after sleeve gastrectomy at 1 year?
  • Which component is essential in the adolescent bariatric evaluation?
  • What is a common consequence of obesity-related stigma in patient care?
  • What is the general guideline regarding weight management pharmacotherapy during pregnancy?
  • What is the shape of the relationship between birth weight and subsequent obesity based on the source findings?
  • In therapy for type 2 diabetes, the addition of insulin is most effective when combined with which oral agent?
  • Which of the following is a contraindication to bariatric surgery?
  • Which incretin-based therapy has shown the greatest glucose-lowering efficacy and weight loss potential in trials?
  • Which two GI side effects are commonly associated with orlistat and can affect adherence?
  • What waist circumference thresholds are commonly used to indicate increased cardiometabolic risk?
  • What is the typical percentage weight loss range within 1-2 years after Roux-en-Y gastric bypass?
  • Which guideline body is commonly referenced for obesity management guidelines, including categorizing obesity severity and guiding therapy?
  • Which is a key component of pre-surgical evaluation for bariatric/metabolic surgery?
  • What components should be included when initiating anti-obesity medications to maximize success?
  • Which obesity pharmacotherapy should be used with caution due to risk of nephrolithiasis?
  • What method is commonly used to measure body composition changes during weight management trials?
  • Which statement about sleeve gastrectomy is true?
  • By how much does all-cause mortality decrease after Roux-en-Y gastric bypass, largely due to reductions in cardiovascular and cancer mortality?
  • What is a major contraindication to initiating phentermine/topiramate therapy?
  • Postoperative monitoring after bariatric surgery focuses on which of the following?
  • What are key considerations for bariatric surgery in adolescents with severe obesity?
  • What is the impact of patient stigma on obesity care, and what strategy effectively mitigates it?
  • Postoperative long-term complications after gastric bypass include significant weight regain and which of the following?
  • In public health messaging, obesity has become the leading cause of which of the following?
  • What is weight cycling and what are its potential health implications?
  • Which obesity pharmacotherapy combines naltrexone and bupropion?
  • After initial weight loss, what maintenance weight change range is generally considered stable?
  • When discussing weight with a patient, which term is recommended to minimize stigma?
  • Which factor best predicts the effectiveness of weight loss interventions?
  • What factors influence the choice between pharmacotherapy and bariatric surgery?
  • In the fasting state, which statement best describes changes in neurotransmitter circuits?
  • Which statement best describes the relationship between obesity and genetics in management?
  • A 38-year-old man with type 2 diabetes who gained weight on glyburide and had improved HbA1c on metformin; after discontinuing glyburide, which medication would be most beneficial to add?
  • Which of the following is a common adverse event with GLP-1 receptor agonists?
  • In a study of calorie-deficit diets with matched weight loss, which macronutrient modification was associated with improved triglycerides and HDL?
  • What preoperative assessment is essential before bariatric surgery to assess mental health and eating behavior?
  • Which statement best reflects the role of sleep quality in metabolic regulation?
  • Which of the following is NOT a common GI adverse event associated with GLP-1 receptor agonists?
  • What is a goal of shared-decision making?
  • Which obesity medication is a once-weekly GLP-1 receptor agonist approved for weight management?
  • Which syndrome may occur in association with thiamine deficiency after Roux-en-Y gastric bypass?
  • How does sleep influence obesity risk?
  • Which statement aligns with obesity management guidelines?
  • In a patient considered for lorcaserin, the drug should be used with caution in the presence of which condition?
  • Which obesity medication carries an increased risk of nephrolithiasis and should be used with caution in patients with kidney stones?
  • Which adverse effect on metformin led to switching to glyburide in this case?
  • What minimum weight loss is needed to see therapeutic benefit across obesity-related comorbidities in this scenario?
  • Which comorbidity tends to abate after bariatric surgery?
  • Which finding most strongly suggests sleep apnea in a patient with daytime sleepiness?
  • What daily energy deficit is commonly recommended to achieve about 0.5-1 kg weight loss per week?
  • What is dumping syndrome and after which bariatric procedure is it most associated?
  • In the context of very-low-calorie diets, when is such an approach appropriate?
  • What does the term 'set point' refer to in obesity?
  • Which of the following is commonly recommended as an initial weight loss goal to improve cardiometabolic risk?
  • What is the maximum approved daily dose of orlistat for adults?
  • Which safety considerations are important when using GLP-1 receptor agonists for weight management?
  • Which factor increases the risk of cardiovascular disorders in patients with obesity?
  • Excess abdominal fat is associated with which cluster of metabolic abnormalities?
  • Approximately how many calories are expended in postprandial thermogenesis for a man who consumes 2,200 kcal per day?
  • Which test is best to confirm a diagnosis of diabetes mellitus in a patient with classic symptoms and signs?
  • Which test is more sensitive for diagnosing diabetes and impaired glucose tolerance but is less convenient and is rarely used routinely except for gestational diabetes and research?
  • In SURMOUNT-1, the population consisted of individuals with obesity or overweight who had what diabetes status?
  • What BMI threshold defines obesity in adults?
  • In managing metabolic syndrome, which measures are emphasized?
  • In the first year of obesity treatment, what is the typical follow-up visit frequency during medication titration?
  • Short-acting insulin secretagogues (eg, repaglinide, nateglinide) are especially effective for which outcome?
  • Which set of components defines metabolic syndrome that may improve with weight loss?
  • Which communication approach best aligns with patient-centered obesity care?
  • Which factor decreases leptin secretion?
  • Metabolic syndrome is very common among older adults. Which statement about the prevalence is most accurate?
  • Which strategy is used to promote SDM?
  • In initial evaluation, which two conditions are commonly screened as secondary causes of obesity?
  • Postprandial thermogenesis accounts for about what percentage of daily energy expenditure in a typical adult?
  • Which modality provides the most accurate measurement of multiregional body fat distribution?
  • Which weight-loss medication class would be most beneficial to add to the regimen in a patient who failed previous therapy, as described in the case?
  • In a structured diet plan, why might uncounted fruit servings lead to slower weight loss?
  • Which statement about obesity genetics is true?
  • Which statement best describes the role of ongoing support in obesity treatment?
  • Which obesity medication is contraindicated in a patient on monoamine oxidase inhibitors?
  • According to ADA guidelines, which race/ethnicity demographic has lower BMI cutoffs?
  • What is a commonly recommended practice when initiating GLP-1 receptor agonists to minimize GI side effects?
  • This type of behavior therapy is referred to as limiting exposure to cues that trigger overeating?
  • A 45-year-old Japanese-American man with a BMI of 23 kg/m2 and a waist circumference of 92 cm has a higher risk for type 2 diabetes compared with Caucasians. How should his risk be classified?
  • Phentermine/topiramate ER is contraindicated in which patient scenario?
  • In motivational interviewing, this response illustrates which technique?
  • What BMI and comorbidity thresholds typically define eligibility for bariatric/metabolic surgery?
  • In a randomized trial of two calorie-deficit diets for individuals with metabolic syndrome, Diet A produced better triglyceride, glucose, and HDL outcomes, despite equal weight loss, due to what macronutrient difference?
  • Which statement about obesity treatment guidelines is most accurate?
  • According to Prochaska's Stages of Change, which stage describes a person who acknowledges weight-related health risks but has not yet started taking steps toward change?
  • Which preexisting condition has been shown to go into remission in up to 62% of patients 6 years after Roux-en-Y gastric bypass?
  • In head-to-head trial comparing tirzepatide to semaglutide, which had greater HbA1c reduction and weight loss at similar doses?
  • What is the general management sequence for a patient with obesity and NAFLD without cirrhosis?
  • How does set point theory influence long-term obesity treatment planning?
  • According to AHA/ACC/TOS guidelines, what is a recommended approach for low-calorie dieting in terms of daily energy deficit or total intake for women?
  • In motivational interviewing, which question structure is used to draw out change talk by clarifying why a patient assigns a moderate importance rather than high?
  • Which antihypertensive medication is most likely to explain a 5%-10% reduction in total energy expenditure?
  • Describe the mechanism of action of phentermine/topiramate in obesity treatment and the main safety concern.
  • Obesity is best defined as a chronic disease. Which statement best reflects this definition?
  • Which vitamins/minerals are most commonly deficient after bariatric surgery?
  • In the 5A framework, which is the first step in managing overweight or obesity?
  • A patient who recently underwent Roux-en-Y gastric bypass presents five days later with abdominal pain radiating to the chest, tachycardia, and leukocytosis. Which complication is most likely?
  • In screening for metabolic syndrome, which laboratory test is most appropriate given a family history of type 2 diabetes and a large waist circumference?
  • What is the typical percent weight loss after Roux-en-Y gastric bypass at 2 years?
  • What two elements are essential to reduce weight regain long-term?
  • Which statement best captures obesity pathophysiology?
  • What are the key elements of a patient-centered approach in obesity care?
  • During childhood and adolescence, how does body mass index typically change?
  • A patient four weeks after Roux-en-Y gastric bypass presents with progressive nausea, vomiting, and dysphagia. Which complication should be suspected?
  • Four weeks after starting weight loss counseling for a child with BMI in the 98th percentile, weight loss occurred without increased activity. What is the most appropriate next step?
  • A GLP-1 receptor agonist was started in a patient who reports gastrointestinal issues. What is the best way to manage these common side effects?
  • In obesity with NAFLD, what laboratory monitoring is recommended during weight management?
  • In rhabdomyolysis, which laboratory finding is most characteristic?
  • Which of the following is not typically considered when deciding between pharmacotherapy and bariatric surgery?
  • When should transition from titration to maintenance follow-up occur?
  • Which metabolic risk factor is commonly improved with weight loss?
  • Which obesity medication is a once-weekly GLP-1 receptor agonist approved for weight management at 2.4 mg?
  • What is the rationale for using anti-obesity medications as part of treatment?
  • Based on Asian-specific BMI thresholds, this patient with BMI 27.8 would be categorized as which risk class?
  • Which lab tests are routinely monitored to assess diabetes risk/control during weight management?
  • In counseling a patient about second-generation anti-obesity medications, which statement best reflects a shared-decision-making approach?
  • What are the primary goals of a comprehensive obesity management program?
  • What term describes the disproportionate decrease in resting metabolic rate after weight loss, contributing to weight regain?
  • Which effect is hypothesized to be mediated by GIP receptor activation in obesity therapies?
  • Which alternative technique is commonly used when DEXA is not available to assess body composition?
  • Which dietary pattern is consistently associated with favorable cardiovascular risk reduction and is commonly recommended in obesity management?
  • Which statement about lorcaserin is most consistent with the source material?
  • Which diabetes medication class is least associated with weight loss?
  • Which liver enzyme is commonly monitored to assess NAFLD response to weight loss?
  • Which statement about HbA1c testing for diagnosing diabetes is true?
  • Why is the word obese often avoided when discussing weight with patients?
  • Which statement best describes the relationship between weight loss and improvement in comorbidities?
  • Which statement about initial obesity evaluation is true?
  • Which obesity medication is a once-daily injectable GLP-1 receptor agonist dosed at 3.0 mg for weight management and carries a boxed warning for thyroid C-cell risk?
  • Which imaging modality is preferred for accurately assessing fat distribution across multiple regions?
  • Which procedure is being used increasingly in the United States as definitive treatment for severe obesity (BMI greater than 60)?
  • Which body composition component is the principal contributor to resting energy expenditure?
  • What is the typical weight loss range after sleeve gastrectomy at 1 year?
  • What is the role of ghrelin in food intake regulation?
  • Which measurements are needed to calculate the body mass index (BMI)?
  • Which laboratory test combination is appropriate to monitor vitamin D status, PTH, and B12 after bariatric surgery?
  • For a five-year-old adopted child with short stature and high weight percentiles, what is the most appropriate next step?
  • Which obesity medications carry boxed warnings about the risk of thyroid C-cell tumors?
  • Which strategy best supports maintaining weight loss after discontinuing pharmacotherapy?
  • Which class of obesity medications does liraglutide belong to?
  • What strategy supports maintaining weight loss after discontinuing pharmacotherapy?
  • What counseling approach is emphasized to enhance readiness to change in obesity treatment?
  • A 48-year-old woman six weeks after bariatric surgery presents with nausea, vomiting, edema, numbness, tingling in her feet, and brain fog. Which nutritional deficiency is most likely?
  • In the described patient with obesity and dyslipidemia (TG 210 mg/dL and LDL 152 mg/dL), which lipid abnormalities are present?
  • Which drug is not used in the treatment of metabolic syndrome?
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy